Evidence map›Paper›PMID 33408403›Full record

ArticleNature methods2021

Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM.

Tomasz Uchański, Simonas Masiulis, Baptiste Fischer, Valentina Kalichuk, Uriel López-Sánchez, Eleftherios Zarkadas, Miriam Weckener, Andrija Sente, Philip Ward, Alexandre Wohlkönig and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
18.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 149 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Visualization of the interaction between sphingomyelin and cholesterol in lipid bilayer membranes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Structural analysis of rhodopsin states in megabody complexes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Hidden gems bring proteins into view.Nature chemical biology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Tomasz UchańskiStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium.ORCID http://orcid.org/0000-0001-8456-4206
Simonas MasiulisMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
Baptiste FischerStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium.
Valentina KalichukStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium.
Uriel López-SánchezCNRS, Université Grenoble Alpes, CEA, Institut de Biologie Structurale, Grenoble, France.ORCID http://orcid.org/0000-0003-4937-7055
Eleftherios ZarkadasCNRS, Université Grenoble Alpes, CEA, Institut de Biologie Structurale, Grenoble, France.ORCID http://orcid.org/0000-0002-9276-9831
Miriam WeckenerRosalind Franklin Institute, Rutherford Appleton Laboratory, Didcot, UK.ORCID http://orcid.org/0000-0002-1419-9378
Andrija SenteMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.ORCID http://orcid.org/0000-0001-5407-9138
Philip WardDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-2546-3426
Alexandre WohlkönigStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium.
Thomas ZöggStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium.ORCID http://orcid.org/0000-0003-0454-4227
Han RemautStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium.ORCID http://orcid.org/0000-0002-9775-4102
James H NaismithRosalind Franklin Institute, Rutherford Appleton Laboratory, Didcot, UK.ORCID http://orcid.org/0000-0001-6744-5061
Hugues NuryCNRS, Université Grenoble Alpes, CEA, Institut de Biologie Structurale, Grenoble, France.
Wim VrankenStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium.ORCID http://orcid.org/0000-0001-7470-4324
A Radu AricescuMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK. radu@mrc-lmb.cam.ac.uk.ORCID http://orcid.org/0000-0003-3783-1388
Els PardonStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium.ORCID http://orcid.org/0000-0002-2466-0172
Jan SteyaertStructural Biology Brussels, Vrije Universiteit Brussel, VUB, Brussels, Belgium. Jan.steyaert@vub.be.ORCID http://orcid.org/0000-0002-3825-874X
Vrije Universiteit Brussel · BECentre National de la Recherche Scientifique · FRCentre for Human Genetics · GBMRC Laboratory of Molecular Biology · GBRutherford Appleton Laboratory · GB

Funding

Medical Research Council 638467Medical Research Council MC_EX_MR/L009609/2Medical Research Council MC_PC_17137Medical Research Council MC_UP_1201/15Medical Research Council MR/L009609/1Wellcome TrustWellcome Trust 060208/Z/00/ZWellcome Trust 093305/Z/10/Z
6 · The paper itself

Abstract

Nanobodies are popular and versatile tools for structural biology. They have a compact single immunoglobulin domain organization, bind target proteins with high affinities while reducing their conformational heterogeneity and stabilize multi-protein complexes. Here we demonstrate that engineered nanobodies can also help overcome two major obstacles that limit the resolution of single-particle cryo-electron microscopy reconstructions: particle size and preferential orientation at the water-air interfaces. We have developed and characterized constructs, termed megabodies, by grafting nanobodies onto selected protein scaffolds to increase their molecular weight while retaining the full antigen-binding specificity and affinity. We show that the megabody design principles are applicable to different scaffold proteins and recognition domains of compatible geometries and are amenable for efficient selection from yeast display libraries. Moreover, we demonstrate that megabodies can be used to obtain three-dimensional reconstructions for membrane proteins that suffer from severe preferential orientation or are otherwise too small to allow accurate particle alignment.

Indexed as

Cryoelectron MicroscopyHumansLipidsModels, MolecularMolecular StructureMultiprotein ComplexesProtein ConformationReceptors, GABA-ASingle-Cell AnalysisSingle-Domain AntibodiesSingle Molecule ImagingGABRB3 protein, humanLipidsMultiprotein ComplexesReceptors, GABA-ASingle-Domain Antibodies

Identifiers

PMID33408403
PMCPMC7611088
OpenAlexW3120145943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.